[go: up one dir, main page]

NO20055493D0 - 8??-vinyl-11??-(w-substituerte)alkyl-ostra-1,3,5(10)-triener - Google Patents

8??-vinyl-11??-(w-substituerte)alkyl-ostra-1,3,5(10)-triener

Info

Publication number
NO20055493D0
NO20055493D0 NO20055493A NO20055493A NO20055493D0 NO 20055493 D0 NO20055493 D0 NO 20055493D0 NO 20055493 A NO20055493 A NO 20055493A NO 20055493 A NO20055493 A NO 20055493A NO 20055493 D0 NO20055493 D0 NO 20055493D0
Authority
NO
Norway
Prior art keywords
estra
triene
vinyl
substituted
alkyl
Prior art date
Application number
NO20055493A
Other languages
English (en)
Other versions
NO20055493L (no
Inventor
Rolf Bohlmann
Olaf Peters
Nico Brauer
Alexander Hillisch
Hans-Peter Muhn
Margit Richter
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20055493D0 publication Critical patent/NO20055493D0/no
Publication of NO20055493L publication Critical patent/NO20055493L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO20055493A 2003-04-22 2005-11-21 8β-vinyl-11β-(w-substituerte)alkyl-ostra-1,3,5(10)-triener NO20055493L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10318896A DE10318896A1 (de) 2003-04-22 2003-04-22 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene
PCT/EP2004/004086 WO2004094451A2 (de) 2003-04-22 2004-04-16 8beta-vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene

Publications (2)

Publication Number Publication Date
NO20055493D0 true NO20055493D0 (no) 2005-11-21
NO20055493L NO20055493L (no) 2006-01-18

Family

ID=33304956

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055493A NO20055493L (no) 2003-04-22 2005-11-21 8β-vinyl-11β-(w-substituerte)alkyl-ostra-1,3,5(10)-triener

Country Status (21)

Country Link
US (1) US7375098B2 (no)
EP (1) EP1622924A2 (no)
JP (1) JP2006524202A (no)
KR (1) KR20060005386A (no)
CN (1) CN100381457C (no)
AR (1) AR044056A1 (no)
AU (1) AU2004232462A1 (no)
BR (1) BRPI0409794A (no)
CA (1) CA2522354A1 (no)
CL (1) CL2004000856A1 (no)
CR (1) CR8053A (no)
DE (1) DE10318896A1 (no)
EA (1) EA009606B1 (no)
EC (1) ECSP056180A (no)
MX (1) MXPA05011386A (no)
NO (1) NO20055493L (no)
PE (1) PE20050423A1 (no)
RS (1) RS20050793A (no)
UY (1) UY28284A1 (no)
WO (1) WO2004094451A2 (no)
ZA (1) ZA200509447B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2245694T3 (es) * 2000-04-12 2006-01-16 Schering Aktiengesellschaft Derivados de 11beta-pentil- y 11beta-hexil-estra-1,3,5(10)-trienos sustituidos en la posicion 8beta.
CN101052641A (zh) 2004-09-07 2007-10-10 惠氏公司 6H-[1]苯并吡喃并[4,3-b]喹啉及其作为雌激素药物的用途
CN101272792A (zh) * 2005-10-05 2008-09-24 西科尔公司 氟维司群的分离

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032680A2 (de) * 1999-11-02 2001-05-10 Schering Aktiengesellschaft 18-nor-steroide als selektiv wirksame estrogene
ES2245694T3 (es) * 2000-04-12 2006-01-16 Schering Aktiengesellschaft Derivados de 11beta-pentil- y 11beta-hexil-estra-1,3,5(10)-trienos sustituidos en la posicion 8beta.
DE10151114A1 (de) * 2001-10-15 2003-04-17 Schering Ag 8ß-Substituierte-11ß-aryl-estra-2,3,5(10)-trienderivate

Also Published As

Publication number Publication date
AR044056A1 (es) 2005-08-24
WO2004094451A3 (de) 2004-12-23
JP2006524202A (ja) 2006-10-26
NO20055493L (no) 2006-01-18
CN1777618A (zh) 2006-05-24
ZA200509447B (en) 2009-08-26
CA2522354A1 (en) 2004-11-04
CL2004000856A1 (es) 2005-03-28
US20050065135A1 (en) 2005-03-24
MXPA05011386A (es) 2006-04-18
DE10318896A1 (de) 2004-11-25
EA009606B1 (ru) 2008-02-28
WO2004094451A2 (de) 2004-11-04
US7375098B2 (en) 2008-05-20
KR20060005386A (ko) 2006-01-17
PE20050423A1 (es) 2005-08-13
AU2004232462A1 (en) 2004-11-04
EA200501568A1 (ru) 2006-06-30
RS20050793A (sr) 2008-04-04
EP1622924A2 (de) 2006-02-08
ECSP056180A (es) 2006-04-19
UY28284A1 (es) 2004-11-30
CN100381457C (zh) 2008-04-16
CR8053A (es) 2006-05-29
BRPI0409794A (pt) 2006-05-30

Similar Documents

Publication Publication Date Title
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
DE602004006169D1 (de) Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20053248D0 (no) Kerosenblanding.
BR0305668B1 (pt) compressor.
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
NO20052248D0 (no) Svivelstykkesystem.
FI20020881A (fi) Iskulaite
NO20051500D0 (no) Substituerte heterocyklylpyrimidiner.
ITMI20032170A1 (it) Tagliacimosse.
NO20055493D0 (no) 8??-vinyl-11??-(w-substituerte)alkyl-ostra-1,3,5(10)-triener
NO20051497D0 (no) Beta-laktamaseinhibitorprodrug.
ITMI20030916A1 (it) Lancetta.
ES1052590Y (es) Quiosco-consigna.
DE50301007D1 (de) Sportschuh, insbesondere skischuh
ITMI20020288A1 (it) Do.re.mi
ES1052699Y (es) Piragua desmontable.
ES1051703Y (es) Potera.
ES1051605Y (es) Cromo-puzzle.
ES1051110Y (es) Caja-palet.
ES1052945Y (es) Contraventana.
ES1052938Y (es) Cantonera.
ES1052654Y (es) Cubitera.
ES1052029Y (es) Balin-proyectil.
ES1052011Y (es) Espetero.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application